← Back to patent-cliff list
富马酸比索洛尔
Tier C — Watch / tradeBisoprolol Fumarate
梯瓦
Originator
1986
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRB1
Brand：Concor、Bisocard、Emcor、Congescor、Concor COR、Soprol、Monocor、Euradal、Zebeta、Cardicor、Fondril、Maintate
Indications (approved)：高血压、心绞痛
Regional status
US
撤市
EU
批准上市
1986-01-30
China
批准上市
1997-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bisoprolol Fumarate?
Approved indications include: 高血压, 心绞痛.
When does the Bisoprolol Fumarate patent expire?
No public expiry year is available for Bisoprolol Fumarate yet; this page updates once verified.
How do I get a quote for Bisoprolol Fumarate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25